Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dow Gains as Big Tech Continues Reign; Microsofts Jumps on TikTok Talks

Published 2020-08-03, 12:56 p/m
Updated 2020-08-03, 01:00 p/m
© Reuters.

By Yasin Ebrahim

Investing.com – Wall Street climbed Monday, as big tech continued to rack up gains following bullish earnings last week, while healthcare names rallied on positive coronavirus treatment news.

The Dow Jones Industrial Average rose 0.83%, or 219 points. The S&P 500 gained 0.75%, while the Nasdaq Composite jumped 1.35%.

The "fab 5" megacap tech stocks - with the exception of Alphabet (NASDAQ:GOOGL) - continue to ride on the coattails of their recent wave of bullish earnings, with Amazon (NASDAQ:AMZN), Apple (NASDAQ:AAPL),  Facebook (NASDAQ:FB) and Microsoft (NASDAQ:MSFT), which combined make up about 20% of the S&P 500 index, trading above the flatline.

Microsoft led the gains, up 4% after confirming that it was in talks to buy social media company TikTok from ByteDance.

The move has been cheered by analysts on Wall Street, who believe that the addition of TikTok could boost Microsoft's consumer offering.

"(Satya) Nadella has essentially had the golden touch since becoming CEO… although the missing piece in the puzzle has been a consumer trojan horse strategy which TikTok can fill along with a re-rating/sum-of-the-parts valuation," Wedbush analyst Daniel Ives said in a note.

Beyond tech, healthcare also supported investor sentiment on stocks thanks to signs of progress in the race for a coronavirus treatment.

Eli Lilly (NYSE:LLY) said it would get a phase 3 trial of its experimental coronavirus treatment, LY-CoV555, sending its shares more than 1% higher.

A lack of progress between U.S. lawmakers over the next coronavirus stimulus package, however, kept gains in the broader market in check.  

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Unemployment assistance, set at $600 a week in March, has since lapsed, and renewing it has remained a key sticking for lawmakers.

On the earnings front, Clorox (NYSE:CLX) slipped about 2% despite delivering quarterly results that beat on the top and bottom lines.

In economic news, signs of a turnaround in manufacturing continued.

ISM manufacturing data  for July showed an uptick to 54.2, beating expectations of 53.6. A reading above 50 in the ISM index indicates an expansion in manufacturing, which accounts for about 12% of the U.S. economy.

"We remain confident that manufacturing will be more resilient to Covid-related developments than the service side of the economy, and activity should continue to expand in coming quarters as the recovery takes hold," Jefferies (NYSE:JEF) said in a note.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.